EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Socioeconomic position and its effect on cardiovascular outcomes and mortality in patients with prostate cancer

Tarek Nahle iD, Omar M Makram iD, Viraj R Shah iD, Harikrishnan Hyma Kunhiraman iD, Muhammad Umar Afzal iD, Irbaz Bin Riaz iD, Neeraj Agarwal iD, Umang Swami iD, Jean-Sebastien Rachoin iD, Neal L Weintraub, Avirup Guha iD

JNCI Cancer Spectrum · 2025

DOI: 10.1093/jncics/pkaf113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2025. Verfasst von Tarek Nahle und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, United States. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Prostatic Neoplasms, Social Class. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Department of Defense Prostate Cancer Research Program's Physician Research, American Heart Association-Strategically Focused Research Network Grant in Disparities in Cardio-Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Socioeconomic position (SEP) is a fundamental social determinant of health (SDoH) contributing to observed disparities in cancer and cardiovascular (CV) care among individuals with prostate cancer (PC). Understanding the influence of SEP on CV health is essential for addressing outcome inequities within this population.

Methods

We conducted a retrospective study utilizing Surveillance, Epidemiology, and End Results (SEER)-Medicare to evaluate CV outcomes in patients ≥65 years with PC from 2009 to 2017. We studied the impact of SEP on cardiovascular events (CVEs), cardiovascular mortality (CVm), PC-specific mortality (PCsm), and all-cause mortality. CVE, CVm, and PCsm were analyzed using competing risk models and all-cause mortality with Cox proportional hazards models. A subgroup analysis was performed in Non-Hispanic Black and Non-Hispanic White individuals.

Results

We included 141 242 patients of whom 76 844 were in high SEP areas (45.6%) and 64 398 in low SEP ones (54.4%). Both groups had a mean age of 72 years; patients in low SEP areas were 67.5% Non-Hispanic White, 34.4% having diabetes, 73.3% hypertension, and 67.7% dyslipidemia versus the high SEP group with 85.6% Non-Hispanic White, 30.4% diabetes, 69.9% hypertension, and 70.7% dyslipidemia. Patients in low SEP areas had higher risks of CVm (subdistribution hazard ratio [sHR] = 1.18, 95% CI = 1.12 to 1.25), PCsm (sHR = 1.12, 95% CI = 1.06 to 1.17), CVE (sHR = 1.07, 95% CI = 1.04 to 1.09), and all-cause mortality (HR 1.16, 95% CI = 1.13 to 1.20). Accentuated results were shown in the Non-Hispanic Black subgroup.

Conclusion

Adverse SEP plays a significant role in shaping outcomes among older patients with PC, contributing to elevated risks of adverse CV and survival outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesProstatic NeoplasmsSocial ClassAgedAged, 80 and overHumansMaleBlack or African AmericanDiabetes MellitusHealth Status DisparitiesHypertensionMedicareProportional Hazards ModelsRetrospective StudiesRisk FactorsSEER ProgramSocial Determinants of HealthSocioeconomic FactorsUnited StatesWhite

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, United States.
  • Cardio-Oncology Program, Medical College of Georgia at Augusta University, Augusta, GA, United States.
  • Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, United States.
  • Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ, United States.
  • Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, Unites States.
  • Department of Medicine, Cooper Medical School of Rowan University, Camden, NJ, United States.

ORCID-Profile: Tarek Nahle, Omar M Makram, Viraj R Shah, Harikrishnan Hyma Kunhiraman, Muhammad Umar Afzal, Irbaz Bin Riaz, Neeraj Agarwal, Umang Swami, Jean-Sebastien Rachoin, Avirup Guha

Förderung

  • NCI NIH HHS
  • Department of Defense Prostate Cancer Research Program's Physician Research
  • American Heart Association-Strategically Focused Research Network Grant in Disparities in Cardio-Oncology
  • Department of Defense Prostate Cancer Research Program’s Physician Research

Zitieren

APA

Nahle, T., Makram, O. M., Shah, V. R., Hyma Kunhiraman, H., Afzal, M. U., Riaz, I. B., Agarwal, N., Swami, U., Rachoin, J. S., Weintraub, N. L., & Guha, A. (2025). Socioeconomic position and its effect on cardiovascular outcomes and mortality in patients with prostate cancer. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf113

Vancouver

Nahle T, Makram OM, Shah VR, Hyma Kunhiraman H, Afzal MU, Riaz IB, et al. Socioeconomic position and its effect on cardiovascular outcomes and mortality in patients with prostate cancer. JNCI Cancer Spectrum. 2025. doi:10.1093/jncics/pkaf113

BibTeX
@article{Nahle2025,
  author = {Nahle, Tarek and Makram, Omar M and Shah, Viraj R and Hyma Kunhiraman, Harikrishnan and Afzal, Muhammad Umar and Riaz, Irbaz Bin and Agarwal, Neeraj and Swami, Umang and Rachoin, Jean-Sebastien and Weintraub, Neal L and Guha, Avirup},
  title = {Socioeconomic position and its effect on cardiovascular outcomes and mortality in patients with prostate cancer},
  journal = {JNCI Cancer Spectrum},
  year = {2025},
  doi = {10.1093/jncics/pkaf113}
}
Kostenlos starten →